vs
Side-by-side financial comparison of Chatham Lodging Trust (CLDT) and Twist Bioscience Corp (TWST). Click either name above to swap in a different company.
Twist Bioscience Corp is the larger business by last-quarter revenue ($103.7M vs $67.5M, roughly 1.5× Chatham Lodging Trust). Chatham Lodging Trust runs the higher net margin — 1.1% vs -29.4%, a 30.5% gap on every dollar of revenue. On growth, Twist Bioscience Corp posted the faster year-over-year revenue change (16.9% vs -1.6%).
Chatham Lodging Trust is a publicly traded real estate investment trust that invests in, owns, and operates upscale extended-stay and select-service premium hotel properties primarily across high-demand urban and suburban markets in the United States. Its portfolio targets assets with strong occupancy rates and steady cash flow from business and leisure traveler segments.
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
CLDT vs TWST — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $67.5M | $103.7M |
| Net Profit | $725.0K | $-30.5M |
| Gross Margin | — | 52.0% |
| Operating Margin | 2.4% | -31.7% |
| Net Margin | 1.1% | -29.4% |
| Revenue YoY | -1.6% | 16.9% |
| Net Profit YoY | — | 3.4% |
| EPS (diluted) | — | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $67.5M | — | ||
| Q4 25 | $67.7M | $103.7M | ||
| Q3 25 | $78.4M | — | ||
| Q2 25 | $80.3M | — | ||
| Q1 25 | $68.6M | — | ||
| Q4 24 | $75.1M | — | ||
| Q3 24 | $87.2M | — | ||
| Q2 24 | $86.5M | — |
| Q1 26 | $725.0K | — | ||
| Q4 25 | $4.6M | $-30.5M | ||
| Q3 25 | $3.5M | — | ||
| Q2 25 | $5.4M | — | ||
| Q1 25 | $1.5M | — | ||
| Q4 24 | $-1.7M | — | ||
| Q3 24 | $4.3M | — | ||
| Q2 24 | $6.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 52.0% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 40.7% | — | ||
| Q3 24 | 44.7% | — | ||
| Q2 24 | 46.1% | — |
| Q1 26 | 2.4% | — | ||
| Q4 25 | 15.9% | -31.7% | ||
| Q3 25 | 12.7% | — | ||
| Q2 25 | 14.8% | — | ||
| Q1 25 | 12.1% | — | ||
| Q4 24 | 7.5% | — | ||
| Q3 24 | 14.3% | — | ||
| Q2 24 | 16.3% | — |
| Q1 26 | 1.1% | — | ||
| Q4 25 | 6.8% | -29.4% | ||
| Q3 25 | 4.5% | — | ||
| Q2 25 | 6.7% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | -2.3% | — | ||
| Q3 24 | 4.9% | — | ||
| Q2 24 | 7.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | $0.05 | $-0.50 | ||
| Q3 25 | $0.03 | — | ||
| Q2 25 | $0.07 | — | ||
| Q1 25 | $-0.01 | — | ||
| Q4 24 | $-0.08 | — | ||
| Q3 24 | $0.05 | — | ||
| Q2 24 | $0.10 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.7M | $197.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $722.9M | $456.1M |
| Total Assets | $1.2B | $638.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $13.7M | — | ||
| Q4 25 | $24.4M | $197.9M | ||
| Q3 25 | $13.2M | — | ||
| Q2 25 | $17.2M | — | ||
| Q1 25 | $18.6M | — | ||
| Q4 24 | $20.2M | — | ||
| Q3 24 | $19.3M | — | ||
| Q2 24 | $10.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | $338.9M | — | ||
| Q3 25 | $338.8M | — | ||
| Q2 25 | $351.2M | — | ||
| Q1 25 | $381.1M | — | ||
| Q4 24 | $406.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $722.9M | — | ||
| Q4 25 | $740.8M | $456.1M | ||
| Q3 25 | $749.4M | — | ||
| Q2 25 | $754.1M | — | ||
| Q1 25 | $754.7M | — | ||
| Q4 24 | $758.2M | — | ||
| Q3 24 | $765.3M | — | ||
| Q2 24 | $766.5M | — |
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | $638.1M | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.46× | — | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | 0.47× | — | ||
| Q1 25 | 0.50× | — | ||
| Q4 24 | 0.54× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-24.8M |
| Free Cash FlowOCF − Capex | — | $-34.8M |
| FCF MarginFCF / Revenue | — | -33.5% |
| Capex IntensityCapex / Revenue | — | 9.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $64.1M | $-24.8M | ||
| Q3 25 | $25.6M | — | ||
| Q2 25 | $22.1M | — | ||
| Q1 25 | $4.2M | — | ||
| Q4 24 | $73.8M | — | ||
| Q3 24 | $28.8M | — | ||
| Q2 24 | $25.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $-34.8M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | -33.5% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 9.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 13.90× | — | ||
| Q3 25 | 7.24× | — | ||
| Q2 25 | 4.10× | — | ||
| Q1 25 | 2.73× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 6.78× | — | ||
| Q2 24 | 3.68× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLDT
| Room | $61.2M | 91% |
| Other | $4.7M | 7% |
| Food and beverage | $1.6M | 2% |
TWST
| Industrial Chemicals | $37.2M | 36% |
| Diagnostics | $35.3M | 34% |
| Food Or Agriculture | $12.8M | 12% |
| Academic Research | $12.2M | 12% |
| Health Care | $6.1M | 6% |
